PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcmrmBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Medical Research Methodology
 
BMC Med Res Methodol. 2012; 12: 11.
Published online Feb 6, 2012. doi:  10.1186/1471-2288-12-11
PMCID: PMC3311602
Quality assessment of expert answers to lay questions about cystic fibrosis from various language zones in Europe: the ECORN-CF project
Daniela d'Alquen,corresponding author1 Kris De Boeck,2 Judy Bradley,3 Věra Vávrová,4 Birgit Dembski,5 Thomas OF Wagner,6 Annette Pfalz,6 and Helge Hebestreit1
1Department of Pediatrics, University Hospital Wuerzburg, Josef-Schneider-Str. 2, 97080 Wuerzburg, Germany
2Pediatric Pulmonology, Department of Pediatrics, University Hospital of Leuven, Herestraat 49, 3000 Leuven, Belgium
3Health and Rehabilitation Sciences Research Institute, University of Ulster and Adult CF Centre, Belfast Health and Social Care Trust, Shore Road, Newtownabbey BT37 0QB, Northern Ireland
4Cystic Fibrosis Centre, Charles University, 2nd School of Medicine, V Uvalu 84, 15006 Prague 5, Czech Republic
5CF Europe, Bonn, and CF Association, Mukoviszidose e.V., In den Dauen 6, 53117 Bonn, Germany
6Department of Pneumology, Goethe University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
corresponding authorCorresponding author.
Daniela d'Alquen: DAlquen_D/at/kinderklinik.uni-wuerzburg.de; Kris De Boeck: Christiane.DeBoeck/at/uz.kuleuven.ac.be; Judy Bradley: jm.bradley/at/ulster.ac.uk; Věra Vávrová: vera.vavrova/at/lfmotol.cuni.cz; Birgit Dembski: bdembski/at/muko.info; Thomas OF Wagner: t.wagner/at/em.uni-frankfurt.de; Annette Pfalz: pfalz/at/em.uni-frankfurt.de; Helge Hebestreit: Hebestreit_H/at/kinderklinik.uni-wuerzburg.de
Received May 3, 2011; Accepted February 6, 2012.
Abstract
Background
The European Centres of Reference Network for Cystic Fibrosis (ECORN-CF) established an Internet forum which provides the opportunity for CF patients and other interested people to ask experts questions about CF in their mother language. The objectives of this study were to: 1) develop a detailed quality assessment tool to analyze quality of expert answers, 2) evaluate the intra- and inter-rater agreement of this tool, and 3) explore changes in the quality of expert answers over the time frame of the project.
Methods
The quality assessment tool was developed by an expert panel. Five experts within the ECORN-CF project used the quality assessment tool to analyze the quality of 108 expert answers published on ECORN-CF from six language zones. 25 expert answers were scored at two time points, one year apart. Quality of answers was also assessed at an early and later period of the project. Individual rater scores and group mean scores were analyzed for each expert answer.
Results
A scoring system and training manual were developed analyzing two quality categories of answers: content and formal quality. For content quality, the grades based on group mean scores for all raters showed substantial agreement between two time points, however this was not the case for the grades based on individual rater scores. For formal quality the grades based on group mean scores showed only slight agreement between two time points and there was also poor agreement between time points for the individual grades. The inter-rater agreement for content quality was fair (mean kappa value 0.232 ± 0.036, p < 0.001) while only slight agreement was observed for the grades of the formal quality (mean kappa value 0.105 ± 0.024, p < 0.001). The quality of expert answers was rated high (four language zones) or satisfactory (two language zones) and did not change over time.
Conclusions
The quality assessment tool described in this study was feasible and reliable when content quality was assessed by a group of raters. Within ECORN-CF, the tool will help ensure that CF patients all over Europe have equal possibility of access to high quality expert advice on their illness.
Articles from BMC Medical Research Methodology are provided here courtesy of
BioMed Central